Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072604 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study Comparing Aspirin and Aspirin Granules
A Phase 1 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01072604 is a Phase 1 study that has completed, run by Bayer. The registered enrollment target is 30 participants.
The verdict
NCT01072604, a Phase 1 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects
Interventions
- DRUG Acetylsalicylic acid (Aspirin, BAY1019036)
- DRUG Acetylsalicylic acid (Aspirin, BAYE4465)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072604
The ClinicalTrials.gov registry entry for NCT01072604 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetylsalicylic acid (Aspirin, BAY1019036) is the first listed.
NCT01072604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01072604 about?
NCT01072604 is a clinical study titled "Pharmacokinetic Study Comparing Aspirin and Aspirin Granules". To determine the bioequivalence of new formula of aspirin relative to the established commercial aspirin plain tablet and aspirin dry granules when taken orally by healthy adult subjects
What is the current status of trial NCT01072604?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01072604?
The interventions under investigation include: Acetylsalicylic acid (Aspirin, BAY1019036) (DRUG), Acetylsalicylic acid (Aspirin, BAYE4465) (DRUG).
Who is sponsoring clinical trial NCT01072604?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.